Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
- PMID: 2136891
Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
Abstract
Mechanisms of cyclophosphamide (CP)-induced tolerance were studied. When AKR/J Sea (AKR: H-2k) mice were primed i.v. with 5 x 10(7) spleen cells plus 1 x 10(7) bone marrow cells from [C57BL/6 Slc (B6; H-2b) x C3H/He Slc (C3H; H-2k)]F1 (B6C3F1) mice and treated i.p. with 200 mg/kg CP 2 days later, the survival of C3H skin was moderately prolonged, but the survival of either B6 or B6C3F1 skin was not prolonged. By this treatment, however, mixed chimerism of B6C3F1 cells in the AKR mice was not established. When C3H cells were used as the tolerogen, a minimal degree of mixed chimerism associated with profound tolerance to C3H skin was established. Similar results were observed in various donor-recipient combinations. When C3H skin was grafted in the AKR mice 12 wk after the treatment with C3H cells and CP, or B6C3F1 cells and CP, survival of the grafted C3H skin was prolonged remarkably or moderately, respectively, although mixed chimerism was not detectable at the timing of grafting in either of the groups. In this late stage of tolerance, a strong level of tolerogen-specific suppressor cell activity was observed in those tolerant AKR mice. The suppressor activity was mainly attributable to T cells. These results suggest that the role of Ts cells in order to maintain skin tolerance is important in our CP-induced tolerance system, especially in the late stage of tolerance. Moreover, the generation of the Ts cells does not necessarily require the establishment of a long term mixed chimeric state.
Similar articles
-
Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.Transpl Int. 2005 May;17(12):795-803. doi: 10.1007/s00147-003-0675-2. Epub 2005 Apr 23. Transpl Int. 2005. PMID: 15856178
-
The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.Eur J Immunol. 1990 Sep;20(9):2005-13. doi: 10.1002/eji.1830200919. Eur J Immunol. 1990. PMID: 2209702
-
Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.J Immunol. 1991 Mar 1;146(5):1402-9. J Immunol. 1991. PMID: 1671578
-
Cyclophosphamide-induced chimera-type tolerance to allografts: an overview of drug-induced immunological tolerance.Fukuoka Igaku Zasshi. 1990 Jan;81(1):20-39. Fukuoka Igaku Zasshi. 1990. PMID: 2182492 Review.
-
[Cyclophosphamide-induced immunological tolerance: an overview].Nihon Geka Gakkai Zasshi. 1996 Dec;97(12):1097-108. Nihon Geka Gakkai Zasshi. 1996. PMID: 9032788 Review. Japanese.
Cited by
-
Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.Immunology. 1993 Jan;78(1):113-21. Immunology. 1993. PMID: 8436396 Free PMC article.
-
The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.Biol Blood Marrow Transplant. 2020 Jan;26(1):123-131. doi: 10.1016/j.bbmt.2019.09.024. Epub 2019 Sep 26. Biol Blood Marrow Transplant. 2020. PMID: 31563575 Free PMC article. Clinical Trial.
-
Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application.Front Immunol. 2020 Jan 31;10:3138. doi: 10.3389/fimmu.2019.03138. eCollection 2019. Front Immunol. 2020. PMID: 32082305 Free PMC article. Review.
-
Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.J Clin Invest. 2019 Mar 26;129(6):2357-2373. doi: 10.1172/JCI124218. J Clin Invest. 2019. PMID: 30913039 Free PMC article.
-
Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation.Front Immunol. 2020 Feb 14;11:191. doi: 10.3389/fimmu.2020.00191. eCollection 2020. Front Immunol. 2020. PMID: 32117310 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous